Thus, future efforts could be directed at delivering HDAC inhibitors, bacteria engineered to over-produce n-butyrate (87, 88), n-butyrate producing Lactobacillus strains (81), or n-butyrate analogs to treat endometriosis. This evidence concerns the gene HDAC9 and endometriosis.